cdn mobile

BuCor tip leads NBI to P60-M drugs haul in Metro Manila

By: Inquirer.net July 24,2017 - 11:03 PM

NBI Director Dante Gierran (second from right) presented to the public the seized drugs in Ermita on Friday. With him was NBI Spokesman Ferdinand Lavin (right) and the members of the NBI Forensic Chemistry Division.
/Inquirer photo

The National Bureau of Investigation (NBI) seized more than 10 kilos of dangerous drugs in Manila Friday with a street value of about P60 million.

NBI Director Dante A. Gierran on Monday said he ordered the investigation following a request for assistance from Bureau of Corrections (BuCor).

BuCor sought assistance from the NBI to arrest a group that is allegedly involved in large scale selling of drugs in Metro Manila.

The NBI’ Task Force Against Illegal Drugs (NBI-TFAID) along with the BuCor conducted a counter-action. Authorities found the illegal drugs inside an abandoned vehicle parked along the sidewalk in Ermita, Manila.

An NBI forensic study showed the substance having “positive indication for the presence of Dimethoxy Methylphenethylanime,” an ingredient in psychedelic or hallucinogenic drugs.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: BuCor, drugs, leads, Manila, Metro, NBI
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.